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Introduction: Currently, the major concern with biomaterial implantation or tissue 
grafting is adverse responses of immune system. To remove these barriers, some 
immunosuppressive drugs are used. But they are associated with adverse effects of 
systemical delivery. Adhesion of immune cells to foreign body by cell adhesion 
molecules such as integrins,triggers their activation that leads to immune response. It 
is demonstrated that this is directed by the ability of dendritic cells (DCs) to drive 
adaptive immune cells in situ toward adverse reactions and play as a bridge between 
innate and adaptive immune cells. Thus our focus is on β2 integrin receptors on DC. 
This study aims to modulate the immune response by inhibiting  β2integrins marker 
on DC. 
Methods and Results:to control of DC maturation,αlβ2 and αmβ2 surface markers 
on DCs should be blocked, hence, the novel aptamer-blocking technique was 
utilized. For this purpose, immature DCs (iDC) were derived from human peripheral 
blood monocytes. The antagonist biomolecules (aptamer) that simulated based on 
inverse of DC markers (αlβ2 and αmβ2) from selex,were embedded into injectable 
alginate-branched polyethyleneimine by physical entrapment. Then, derived iDCs 
were treated with synthesized hydrogels in RPMI-1640 media. Interaction of 
released antagonist aptamers from hydrogels andiDC was analyzed. DC adhesion 
and subsequently its maturation and potential for adaptive immune cell activation 
were measured by flowcytometry.When iDCs were treated with hydrogels the levels 
of DC markers (CD80 and CD86) expression as DC maturation criteria were 
measured. Expression level ratio for CD80 and CD86 to control sample show 
significant reduction, about 40 and 50, respectively. Released cytokinesfrom 
administrated DC by trappedaptamerswithAlg-PEI hydrogel indicate that DC 
behavior against a chemical foreign body was modulated considering the amount of 
released cytokines were decreased by10%. 
Conclusions:The results of this study demonstrated that this presented drug delivery 
system based on αlβ2 and αmβ2 aptamers can be used as an immune response 
modulator in health-related application. αlβ2 and αmβ2 aptamers as a new age of 
state of the art drug technology could be a good substitute for monoclonal antibody 
drugs to reduce their side effects and draw backs. 
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